Effect of nutrient supplementation on atopic dermatitis in children: A systematic review of probiotics, prebiotics, formula, and fatty acids

JAMA Dermatology

Volumn 149, Issue 3, 2013, Pages 350-355

  Foolad, Negar ^a   Brezinski, Elizabeth A ^a   Chase, Elizabeth P ^a   Armstrong, April W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GAMMA LINOLENIC ACID; LACTOBACILLUS RHAMNOSUS GG PROBIOTIC; LACTOBACILLUS RHAMNOSUS STRAIN HN001 PROBIOTIC; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTIFICIAL MILK; ATOPIC DERMATITIS; BREAST FEEDING; CHILD; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG MIXTURE; HIGH RISK INFANT; HUMAN; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK REDUCTION; SKIN PROTECTION; SYSTEMATIC REVIEW;

AMINO ACIDS; BREAST FEEDING; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DIETARY SUPPLEMENTS; FATTY ACIDS; FEMALE; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; LACTOBACILLUS RHAMNOSUS; PREBIOTICS; PREGNANCY; PROBIOTICS; SEVERITY OF ILLNESS INDEX;

EID: 84875404684     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.1495     Document Type: Review

References (35)

1. Fölster-Holst R. Probiotics in the treatment and prevention of atopic dermatitis. Ann Nutr Metab. 2010;57(suppl):16-19.
2. Alexander DD, Cabana MD. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. J Pediatr Gastroenterol Nutr. 2010;50(4):422-430.
3. Lee J, Seto D, Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol. 2008;121(1):116-121.
4. Thadhani R, Tonelli M. Cohort studies: marching forward. Clin J Am Soc Nephrol. 2006;1(5):1117-1123.
5. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92(suppl):44-47.
6. Williams HCBP, Burney PG, Pembroke AC, Hay RJ. The UK Working Party's Diagnostic Criteria for Atopic Dermatitis, III: independent hospital validation. Br J Dermatol. 1994;131(3):406-416.
7. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index: Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23-31.
8. Seymour JL, Keswick BH, Hanifin JM, Jordan WP, Milligan MC. Clinical effects of diaper types on the skin of normal infants and infants with atopic dermatitis. J Am Acad Dermatol. 1987;17(6):988-997.
9. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357(9262):1076-1079.
10. Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361(9372):1869-1871.
11. Kim JY, Kwon JH, Ahn SH, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21(2, pt 2):e386-e393.
12. Kitz R, Rose MA, Schönborn H, Zielen S, Böhles HJ. Impact of early dietary gammalinolenic acid supplementation on atopic eczema in infancy. Pediatr Allergy Immunol. 2006;17(2):112-117.
13. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121(4):e850-e856.
14. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119(1):184-191.
15. van Gool CJ, Thijs C, Henquet CJ, et al. Gamma-linolenic acid supplementation for prophylaxis of atopic dermatitis-a randomized controlled trial in infants at high familial risk. Am J Clin Nutr. 2003;77(4):943-951.
16. von Berg A, Koletzko S, Filipiak-Pittroff B, et al; German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol. 2007;119(3):718-725.
17. von Berg A, Koletzko S, Grübl A, et al; German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol. 2003;111(3):533-540.
18. Wickens K, Black PN, Stanley TV, et al; Probiotic Study Group. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122(4):788-794.
19. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138(6):1091-1095.
20. Palmer DJ, Sullivan T, Gold MS, et al. Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial. BMJ. 2012;344:e184.
21. Mallet E, Henocq A. Long-term prevention of allergic diseases by using protein hydrolysate formula in at-risk infants. J Pediatr. 1992;121(5, pt 2):S95-S100.
22. Dotterud CK, Storrø O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol. 2010;163(3):616-623.
23. Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebocontrolled, clinical trial. Am J Clin Dermatol. 2010;11(5):351-361.
24. Leung TF, Ma KC, Cheung LT, et al. A randomized, single-blind and crossover study of an amino acid-based milk formula in treating young children with atopic dermatitis. Pediatr Allergy Immunol. 2004;15(6):558-561.
25. Linnamaa P, Savolainen J, Koulu L, et al. Blackcurrant seed oil for prevention of atopic dermatitis in newborns: a randomized, double-blind, placebo-controlled trial. Clin Exp Allergy. 2010;40(8):1247-1255.
26. Niggemann B, Binder C, Dupont C, Hadji S, Arvola T, Isolauri E. Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol. 2001;12(2):78-82.
27. Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30(11):1604-1610.
28. Grüber C, van Stuijvenberg M, Mosca F, et al; MIPS 1 Working Group. Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol. 2010;126(4):791-797.
29. Salminen S, Bouley C, Boutron-Ruault MC, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr. 1998;80(suppl 1):S147-S171.
30. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003;36(2):223-227.
31. Kalliomäki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebocontrolled trial. J Allergy Clin Immunol. 2007;119(4):1019-1021.
32. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acids and lymphocyte functions. Br J Nutr. 2002;87(suppl 1):S31-S48.
33. Melnik B, Plewig G. Essential fatty acids, eicosanoids and postnatal T-cell maturation: implications for treatment and prevention of atopy. J Dermatolog Treat. 1994;5(3):157-161.
34. Fu PP, Xia Q, Lin G, Chou MW. Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev. 2004;36(1):1-55.
35. Chen T, Mei N, Fu PP. Genotoxicity of pyrrolizidine alkaloids. J Appl Toxicol. 2010;30(3):183-196.